Education
About Us
Working with TipRanks
Follow Us
China Pharma Holdings (CPHI)
:CPHI
RESEARCH TOOLSreports
Total Valuation
China Pharma Holdings has a market cap or net worth of $5.23M. The enterprise value is $23.68M.
Market Cap$5.23M
Enterprise Value$23.68M
Share Statistics
China Pharma Holdings has 3,262,002 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,262,002
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Pharma Holdings’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is <0.01%.
Return on Equity (ROE)-0.60
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)<0.01%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee20.22K
Profits Per Employee-21.14K
Employee Count224
Asset Turnover0.30
Inventory Turnover<0.01
Valuation Ratios
The current PE Ratio of China Pharma Holdings is -8.59. China Pharma Holdings’s PEG ratio is -0.02.
PE Ratio-8.59
PS Ratio0.00
PB Ratio5.88
Price to Fair Value5.13
Price to FCF-31.09
Price to Operating Cash Flow-61.61
PEG Ratio-0.02
Income Statement
In the last 12 months, China Pharma Holdings had revenue of 4.53M and earned -4.74M in profits. Earnings per share was -0.27.
Revenue4.53M
Gross Profit-1.99M
Operating Income-4.59M
Pretax Income-4.74M
Net Income-4.74M
EBITDA-1.96M
Earnings Per Share (EPS)-0.27
Cash Flow
In the last 12 months, operating cash flow was -57.82B and capital expenditures -58.32B, giving a free cash flow of -116.15B billion.
Operating Cash Flow-57.82B
Free Cash Flow-116.15B
Free Cash Flow per Share-35.61K
Dividends & Yields
China Pharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-41.97%
50-Day Moving Average1.86
200-Day Moving Average2.12
Relative Strength Index (RSI)38.56
Average Volume (3m)54.25K
Important Dates
China Pharma Holdings upcoming earnings date is May 15, 2025, TBA Not Confirmed.
Last Earnings DateMay 16, 2024
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
China Pharma Holdings as a current ratio of 0.65, with Debt / Equity ratio of 204.13%
Current Ratio0.65
Quick Ratio0.20
Debt to Market Cap0.09
Net Debt to EBITDA-1.51
Interest Coverage Ratio-29.77
Taxes
In the past 12 months, China Pharma Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China Pharma Holdings EV to EBITDA ratio is -22.23, with an EV/FCF ratio of -57.59.
EV to Sales9.64
EV to EBITDA-22.23
EV to Free Cash Flow-57.59
EV to Operating Cash Flow-93.61
Balance Sheet
China Pharma Holdings has $412.69B in cash and marketable securities with $1.41T in debt, giving a net cash position of $1.00T billion.
Cash & Marketable Securities$412.69B
Total Debt$1.41T
Net Cash$1.00T
Net Cash Per Share$306.62K
Tangible Book Value Per Share$0.07
Margins
Gross margin is -6.09%, with operating margin of -101.32%, and net profit margin of -104.58%.
Gross Margin-6.09%
Operating Margin-101.32%
Pretax Margin-104.58%
Net Profit Margin-104.58%
EBITDA Margin-43.37%
EBIT Margin-101.18%
Analyst Forecast
The average price target for China Pharma Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-33.10%
EPS Growth Forecast71.37%